2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the …

SM Grundy, NJ Stone, AL Bailey, C Beam… - Journal of the American …, 2019 - jacc.org
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on
the Management of Blood Cholesterol: Executive Summary: A Report of the American …

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of …

SM Grundy, NJ Stone, AL Bailey, C Beam… - Journal of the American …, 2019 - jacc.org
The recommendations listed in the present guideline are, whenever possible, evidence
based. An initial extensive evidence review, which included literature derived from research …

Statins for primary prevention in older adults—moving toward evidence‐based decision‐making

S Singh, S Zieman, AS Go, SP Fortmann… - Journal of the …, 2018 - Wiley Online Library
Objectives To determine the efficacy and safety of statins for primary prevention of
atherosclerotic cardiovascular disease (ASCVD) events in older adults, especially those …

Association of statin use with all-cause and cardiovascular mortality in US veterans 75 years and older

AR Orkaby, JA Driver, YL Ho, B Lu, L Costa… - Jama, 2020 - jamanetwork.com
Importance Data are limited regarding statin therapy for primary prevention of atherosclerotic
cardiovascular disease (ASCVD) in adults 75 years and older. Objective To evaluate the …

Role of statin therapy in primary prevention of cardiovascular disease in elderly patients

TE Strandberg - Current atherosclerosis reports, 2019 - Springer
Abstract Purpose of Review Hypercholesterolemia and statin treatment are nowadays
common among people older than 75 years, but clinical heterogeneity in this increasing age …

Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France

P Giral, A Neumann, A Weill, J Coste - European heart journal, 2019 - academic.oup.com
Aims The role of statin therapy in primary prevention of cardiovascular disease in persons
older than 75 years remains a subject of debate with little evidence to support or exclude the …

Statins, mortality, and major adverse cardiovascular events among US veterans with chronic kidney disease

O Barayev, CE Hawley, H Wellman… - JAMA Network …, 2023 - jamanetwork.com
Importance There are limited data for the utility of statins for primary prevention of
atherosclerotic cardiovascular disease (ASCVD) and death in adults with chronic kidney …

Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of …

K Awad, M Mohammed, MM Zaki, AI Abushouk… - BMC medicine, 2021 - Springer
Background Current evidence from randomized controlled trials on statins for primary
prevention of cardiovascular disease (CVD) in older people, especially those aged> 75 …

Health benefits of anti-aging drugs

V Piskovatska, O Strilbytska, A Koliada… - Biochemistry and cell …, 2019 - Springer
Aging, as a physiological process mediated by numerous regulatory pathways and
transcription factors, is manifested by continuous progressive functional decline and …

Statins for primary prevention in those aged 70 years and older: a critical review of recent cholesterol guidelines

CE Hawley, J Roefaro, DE Forman, AR Orkaby - Drugs & aging, 2019 - Springer
The risk of atherosclerotic cardiovascular disease rises with age and remains the leading
cause of death in older adults. Evidence for the use of statins for primary prevention in older …